|
Volumn 137, Issue 7, 2001, Pages 953-955
|
Etanercept-induced injection site reactions: Mechanistic insights from clinical findings and immunohistochemistry
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CD3 ANTIGEN;
CD4 ANTIGEN;
CD8 ANTIGEN;
ETANERCEPT;
HLA DR ANTIGEN;
HYBRID PROTEIN;
IMMUNOGLOBULIN G;
TUMOR NECROSIS FACTOR ALPHA RECEPTOR;
ANTIBODY PRODUCTION;
CLINICAL FEATURE;
DELAYED HYPERSENSITIVITY;
DISCOID LUPUS ERYTHEMATOSUS;
DRUG EFFECT;
DRUG ERUPTION;
DRUG HYPERSENSITIVITY;
DRUG INDUCED DISEASE;
EDITORIAL;
HUMAN;
IMMUNE MEDIATED INJURY;
IMMUNOHISTOCHEMISTRY;
INJECTION SITE;
LEUKOCYTOCLASTIC VASCULITIS;
PATHOGENESIS;
PRIORITY JOURNAL;
T LYMPHOCYTE;
TH2 CELL;
ADJUVANTS, IMMUNOLOGIC;
ANTIGENS, CD;
ARTHRITIS, RHEUMATOID;
CD4-POSITIVE T-LYMPHOCYTES;
CD8-POSITIVE T-LYMPHOCYTES;
DRUG HYPERSENSITIVITY;
HUMANS;
HYPERSENSITIVITY, DELAYED;
IMMUNOGLOBULIN G;
IMMUNOHISTOCHEMISTRY;
IMMUNOPHENOTYPING;
INJECTIONS, INTRADERMAL;
RECEPTORS, TUMOR NECROSIS FACTOR;
|
EID: 0034954391
PISSN: 0003987X
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (28)
|
References (16)
|